Rigel Pharmaceutical Inc. buy Citigroup Inc.
Start price
07.03.24
/
50%
€1.40
Target price
07.03.25
€3.67
Performance (%)
-47.24%
Price
26.06.24
€0.74
Summary
This prediction is currently active. Massive losses of -47.24% have been the result for the BUY prediction by Citigroup_Inc_. This prediction currently runs until 07.03.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rigel Pharmaceutical Inc. | - | - |
iShares Core DAX® | -0.621% | 1.080% |
iShares Nasdaq 100 | -4.503% | -5.432% |
iShares Nikkei 225® | -2.562% | -1.617% |
iShares S&P 500 | -1.706% | -1.223% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat